Bharat Biotech - Page 2 of 3 - EastMojo

Covaxin Bharat Biotech Omicron

Covaxin gets shelf life extension up to 12 months

by Press Trust of India November 3, 2021November 3, 2021

Covaxin Bharat Biotech Omicron

Australia recognises India’s Covaxin

by Press Trust of India November 1, 2021

Obesity speeds up loss of immunity from COVID vaccines – new research

Bharat Biotech’s Covaxin in Oman’s list of approved COVID-19 vaccines

by Press Trust of India October 28, 2021October 28, 2021

Expert panel recommends emergency use approval for Covaxin in 2-18 age group

Expert panel recommends emergency use approval for Covaxin in 2-18 age group

by Press Trust of India October 13, 2021

Covaxin Bharat Biotech Omicron

Coronavirus Updates

Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials

by Press Trust of India September 22, 2021

Covaxin Bharat Biotech Omicron

Bharat Biotech awaits feedback from WHO for Covaxin EUL

by Press Trust of India September 17, 2021September 17, 2021

Covaxin's booster dose works against emerging variants: Bharat Biotech

Coronavirus Updates

Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19: Study

by Press Trust of India August 2, 2021August 2, 2021

Covaxin's booster dose works against emerging variants: Bharat Biotech

Coronavirus Updates

Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

by Press Trust of India June 15, 2021June 15, 2021

Paediatric trials of Covaxin may begin in June: Bharat Biotech official

Paediatric trials of Covaxin may begin in June: Bharat Biotech official

by Press Trust of India May 25, 2021

Covaxin's booster dose works against emerging variants: Bharat Biotech

Coronavirus Updates

Bharat Biotech’s Covaxin approved for phase 2/3 trials on children

by Press Trust of India May 13, 2021May 13, 2021